A global survey of scientists and informaticians reveals growing AI investment across the biopharma value chain, but ...

As clinical trial complexities grow, ICH E6 (R3) updates emphasize smarter monitoring, greater participant focus, and a stronger tech role.

Experts are calling for tailored strategies to enhance the diagnosis, treatment, and monitoring of older people with multiple ...

Revenue cycle management leaders know that the battle for financial performance is increasingly being fought at the intersection of clinical accuracy and operational speed. As denials rise and margins ...

St. Charles County Ambulance District proves that excellence in airway care starts with culture, not complexity — backed by ...

Amplify aims to address the root causes of fragmented health data workflows by using AI and a data-first strategy.

On July 11, 2025, Kevin Feeley, Chief Financial Officer of GeneDx Holdings ( WGS -1.14%), reported the sale of 5,278 shares ...

The opioid crisis stands as one of the most daunting public health challenges of our time, demanding a thoughtful reckoning ...

Why a fundamental reimagining of how clinical studies operate is still necessary to achieve a true paradigm shift—and shed the cycle of reliance on incremental gains.

According to experts at the IAS 2025 meeting in Kigali, Rwanda, AI revolutionizes HIV vaccine development by enhancing design ...

AI offers promise in the realm of chronic disease management, including diabetes, obesity, and PCOS, but must be approached with caution.

The technology, which led to a shift in strategy more than half of the time, could save $719 per symptomatic patient over 10 years.